ALD	Alcoholic liver disease
AHR	Aryl hydrogen receptor
BMI	Body mass index
DAFLD	Dysbiosis-associated fatty liver disease;
DIO	Diet-induced obesity
FFAR 2 and 3	Free fatty acid receptor 2 and 3
FMT	Fecal microbial transplantation
FMT- TRIM	Fecal microbiota transplantation for the improvement of metabolism in obesity
GI	Gastrointestinal tract
GLP-1	Glucagon-like peptide-1 = gluco-regulatory incretin like hormone
GLUT-2	Glucose transporter 2
GPR 41 and 43	G protein coupled receptor 41and 43
HbAc1	Hemoglobin Ac1
HDL	High density lipoprotein
HOMA-IR	Homeostatic model assessment-insulin resistance
IBD	Inflammatory bowel disease
IBS	Irritable bowel syndrome
IFNα,γ	Interferon alpha, gamma
IM	Intestinal microbiome
L cells	Enteroendocrine L cells.
LDL	Low density lipoprotein
LPS	Lipopolysaccharide
MAFLD	Metabolic associated fatty liver disease
MS	Metabolic syndrome
NAFLD	Nonalcoholic fatty liver disease
NFκB	Nuclear factor kappa B
OTUs	Operational taxonomic units
PAMP	Pathogen associated molecular pattern
SCFA	Short chain fatty acids
SIBO	Small intestine bacterial overgrowth
TLR	Toll-like receptor
TMAO	Trimethyl-amine-N-oxide
TGFβ	Transforming growth factor beta
TNFα	Tumor necrosis factor alpha